Dr. John C. Zimmerman, DPM, FACFAS, is a distinguished podiatrist and clinical researcher with an extensive career dedicated to advancing the field of pain management and podiatric medicine. He currently serves as the President of Trovare Clinical Research Inc., a position he has held since 2003, where he spearheads numerous clinical trials aimed at improving treatment outcomes for various pain-related conditions. Dr. Zimmerman has been acting as Principal Investigator in clinical studies for over two decades, demonstrating a consistent commitment to rigorous scientific inquiry and patient care.

Dr. Zimmerman’s clinical research efforts are noteworthy, encompassing a wide range of studies focused on pain management, post-operative care, and the treatment of chronic conditions. Some of his significant research includes randomized controlled trials evaluating the efficacy and safety of medications for managing post-operative pain, opioid-induced constipation, and breakthrough pain in opioid-tolerant patients. His work has been instrumental in developing new therapeutic approaches for pain relief, particularly in patients undergoing orthopedic surgeries and those with chronic non-cancer pain.

Dr. Zimmerman’s contributions to clinical research are also evident in his numerous publications and presentations. Notable works include studies on the efficacy and safety of intravenous meloxicam and tramadol for managing post-operative pain, presented at major scientific meetings and published in the Journal of Clinical Pain.

Through his leadership at Trovare Clinical Research Inc., Dr. Zimmerman continues to influence the landscape of pain management and podiatric medicine, driving forward innovative research that seeks to improve patient care and outcomes. His dedication to clinical research and education underscores his commitment to advancing the field and providing the highest quality of care to his patients.